Literature DB >> 11988601

Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity.

Brett C Meyer1, Thomas M Hemmen, Christy M Jackson, Patrick D Lyden.   

Abstract

BACKGROUND AND
PURPOSE: To prospectively evaluate the reliability and validity of this previously developed stroke scale in an independently collected cohort. The National Institutes of Health Stroke Scale (NIHSS) has been criticized for its complexity and variability. Prior formal clinimetric analyses were used to obtain a modified version of NIHSS (mNIHSS), which retrospectively demonstrated improved reliability and validity. We sought to prospectively measure the reliability and validity of the mNIHSS.
METHODS: Forty-five patients with a history of stroke or intracerebral hemorrhage were evaluated at the University of California, San Diego, Stroke Center from September 2000 through March 2001. Each patient was tested by 2 NIHSS-certified neurologists using the NIHSS, mNIHSS, Barthel Index, and Modified Rankin scales.
RESULTS: There were a large percentage of high kappa values using the mNIHSS. Only 10 (66.67%) of 15 NIHSS kappa scores showed excellent agreement, whereas 10 (90.91%) of 11 mNIHSS kappa scores showed excellent agreement. As predicted, the mNIHSS was more reliable than the NIHSS because of the exclusion of items with low kappa values. With the use of correlation coefficient analysis, the mNIHSS was as valid as the NIHSS.
CONCLUSIONS: This prospective study found high reliability and continued validity by using a previously developed mNIHSS. Items found to have low kappa values were consistent with the previously derived retrospective mNIHSS. The resulting mNIHSS scale has much higher kappa values. The mNIHSS showed improved agreement between examiners and was also easier to administer, having fewer and simpler items. Further prospective evaluation should assess whether the mNIHSS could be used in lieu of the NIHSS.

Entities:  

Mesh:

Year:  2002        PMID: 11988601     DOI: 10.1161/01.str.0000015625.87603.a7

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  50 in total

1.  High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.

Authors:  Fabien Hyafil; Andreas Schindler; Dominik Sepp; Tilman Obenhuber; Anna Bayer-Karpinska; Tobias Boeckh-Behrens; Sabine Höhn; Marcus Hacker; Stephan G Nekolla; Axel Rominger; Martin Dichgans; Markus Schwaiger; Tobias Saam; Holger Poppert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-03       Impact factor: 9.236

2.  Lower NIH stroke scale scores are required to accurately predict a good prognosis in posterior circulation stroke.

Authors:  Violiza Inoa; Abraham W Aron; Ilene Staff; Gilbert Fortunato; Lauren H Sansing
Journal:  Cerebrovasc Dis       Date:  2014-03-25       Impact factor: 2.762

3.  Development of a low-dose protocol for cone beam CT examinations of the anterior maxilla in children.

Authors:  Jose A Hidalgo Rivas; Keith Horner; Badri Thiruvenkatachari; Jonathan Davies; Chrysoula Theodorakou
Journal:  Br J Radiol       Date:  2015-08-17       Impact factor: 3.039

4.  Role of platelet α2-adrenoreceptor in biological low response to Clopidogrel for patients with non cardioembolic ischemic stroke or transient ischemic attack.

Authors:  Jérôme Varvat; Magali Epinat; Aurélie Montmartin; Sandrine Accassat; Claire Boutet; Arnauld Garcin; Guorong Li; Fabrice Malergue; Céline Chapelle; Silvy Laporte; Pierre Garnier; Claude Lambert; Nora Mallouk; Patrick Mismetti
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

5.  Clinical prediction of large vessel occlusion in anterior circulation stroke: mission impossible?

Authors:  Mirjam R Heldner; Kety Hsieh; Anne Broeg-Morvay; Pasquale Mordasini; Monika Bühlmann; Simon Jung; Marcel Arnold; Heinrich P Mattle; Jan Gralla; Urs Fischer
Journal:  J Neurol       Date:  2016-06-06       Impact factor: 4.849

6.  Association between white matter hyperintensities and stroke in a West African patient population: Evidence from the Stroke Investigative Research and Educational Network study.

Authors:  Jingfei Li; Godwin Ogbole; Benjamin Aribisala; Murtala Affini; Joseph Yaria; Issa Kehinde; Mukaila Rahman; Fakunle Adekunle; Rasaq Banjo; Moyinoluwalogo Faniyan; Rufus Akinyemi; Bruce Ovbiagele; Mayowa Owolabi; Steffen Sammet
Journal:  Neuroimage       Date:  2020-04-07       Impact factor: 6.556

7.  Roles of Lesioned and Nonlesioned Hemispheres in Reaching Performance Poststroke.

Authors:  Rachael M Harrington; Evan Chan; Amanda K Rounds; Clinton J Wutzke; Alexander W Dromerick; Peter E Turkeltaub; Michelle L Harris-Love
Journal:  Neurorehabil Neural Repair       Date:  2019-12-20       Impact factor: 3.919

8.  Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study.

Authors:  Brett C Meyer; Rema Raman; Thomas Hemmen; Richard Obler; Justin A Zivin; Ramesh Rao; Ronald G Thomas; Patrick D Lyden
Journal:  Lancet Neurol       Date:  2008-09       Impact factor: 44.182

9.  Poor outcome in primary intracerebral haemorrhage: results of a matched comparison.

Authors:  M Barber; G Roditi; D J Stott; P Langhorne
Journal:  Postgrad Med J       Date:  2004-02       Impact factor: 2.401

10.  Designing and implementing a system for tracking functional status after stroke: a feasibility study.

Authors:  M Elizabeth Sandel; Alan M Jette; Jed Appelman; Joseph Terdiman; Marian TeSelle; Richard L Delmonico; Hua Wang; Michelle Camicia; Elizabeth K Rasch; Diane E Brandt; Leighton Chan
Journal:  PM R       Date:  2012-11-14       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.